Sexual Functioning After Primary Treatment of Ovarian Cancer
- Conditions
- Ovarian CancerSexual Dysfunction
- Interventions
- Behavioral: questionnaires
- Registration Number
- NCT00596544
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to help us learn more about sexual problems after treatment for ovarian cancer. At this time, we do not know how many women have sexual problems after they are treated for ovarian cancer.
How common are sexual problems after treatment for ovarian cancer?
* What factors make women more likely to have sexual problems after treatment for ovarian cancer?
* What happens to sexual functioning over the first 12 months after treatment? ie.
Does it get better or worse?
• Does referral to a specialized sexual health clinic help?
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 18
- Women with any stage of invasive epithelial ovarian cancer who have completed frontline therapy within the past 6 months
- Women must have no clinical evidence of disease
- At least 18 years of age
- English speaking
- Able to participate in the informed consent process
- Women who present to Sexual Health Clinic for the first time and meet all other eligibility criteria are eligible. Their FSFI scores will be used to determine the primary endpoint of prevalence of sexual dysfunction. If they score over 26 on the FSFI, they may still elect to be followed at the SHC.
- Active secondary cancer requiring cytotoxic chemotherapy at the time enrollment
- Evidence of recurrent/persistent disease by elevated CA125, findings on imaging (CT, PET scan etc) or physical examination
- Women with borderline (low malignant potential) ovarian cancers
- Women who are already in active evaluation and/or follow-up at the Sexual Health Clinic
- Women with a history of prior whole pelvic radiation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 questionnaires FSFI score \<= 26 2 questionnaires FSFI score \>26
- Primary Outcome Measures
Name Time Method To estimate the prevalence of sexual dysfunction, as measured by Female Sexual Functioning Index (FSFI) among women who have completed first-line treatment for ovarian cancer within the last 6 months and currently have no evidence of disease. conclusion of study
- Secondary Outcome Measures
Name Time Method To study the natural history of sexual functioning in women after primary treatment of ovarian cancer by using the FSFI at approximately 3, 6 and 12 months. conclusion of study
Trial Locations
- Locations (1)
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States